Ayromlou H - Search Results

1

The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.

Derakhshani A, Asadzadeh Z, Baradaran B, Safarpour H, Rahmani S, Leone P, Abdoli Shadbad M, Hosseinkhani N, Ghasemigol M, Ayromlou H, Ahmadi H, Pouya S, Shojaee M, Tabrizi NJ, Miraki Feriz A, Safarzadeh E, Racanelli V. Derakhshani A, et al. Among authors: ayromlou h. Biomed Pharmacother. 2022 Apr;148:112725. doi: 10.1016/j.biopha.2022.112725. Epub 2022 Feb 17. Biomed Pharmacother. 2022. PMID: 35183994 Free article.

2

Celiac disease and multiple sclerosis in the northwest of Iran.

Khoshbaten M, Farhoudi M, Nikanfar M, Ayromlou H, Shaafi S, Sadreddini SA, Pashapoor A, Taheraghdam A, Yazdchi M, Sharifi N. Khoshbaten M, et al. Among authors: ayromlou h. Bratisl Lek Listy. 2012;113(8):495-7. doi: 10.4149/bll_2012_109. Bratisl Lek Listy. 2012. PMID: 22897375

3

Multiple sclerosis: Therapeutic applications of advancing drug delivery systems.

Dolati S, Babaloo Z, Jadidi-Niaragh F, Ayromlou H, Sadreddini S, Yousefi M. Dolati S, et al. Among authors: ayromlou h. Biomed Pharmacother. 2017 Feb;86:343-353. doi: 10.1016/j.biopha.2016.12.010. Epub 2016 Dec 21. Biomed Pharmacother. 2017. PMID: 28011382 Review.

4

Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis.

Dolati S, Ahmadi M, Rikhtegar R, Babaloo Z, Ayromlou H, Aghebati-Maleki L, Nouri M, Yousefi M. Dolati S, et al. Among authors: ayromlou h. Int Immunopharmacol. 2018 Aug;61:74-81. doi: 10.1016/j.intimp.2018.05.018. Epub 2018 May 28. Int Immunopharmacol. 2018. PMID: 29852475

5

Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis.

Dolati S, Babaloo Z, Ayromlou H, Ahmadi M, Rikhtegar R, Rostamzadeh D, Roshangar L, Nouri M, Mehdizadeh A, Younesi V, Yousefi M. Dolati S, et al. Among authors: ayromlou h. J Neuroimmunol. 2019 Feb 15;327:15-21. doi: 10.1016/j.jneuroim.2019.01.007. Epub 2019 Jan 17. J Neuroimmunol. 2019. PMID: 30683426 Clinical Trial.

6

Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients.

Mousavi SR, Tahmasebivand M, Khorrami M, Ayromlou H, Khalili SK, Khorvash F, Rikhtegar R, Khademi B, Bahmanpour Z, Emamalizadeh B. Mousavi SR, et al. Among authors: ayromlou h. Mult Scler Relat Disord. 2020 Sep;44:102264. doi: 10.1016/j.msard.2020.102264. Epub 2020 Jun 8. Mult Scler Relat Disord. 2020. PMID: 32554287

7

The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls.

Rahmani S, Noorolyai S, Ayromlou H, Khaze Shahgoli V, Shanehbandi D, Baghbani E, Abdoli Shadbad M, Jigari-Asl F, Khamiriyan M, Safaralizadeh R, Baradaran B. Rahmani S, et al. Among authors: ayromlou h. Gene. 2021 Feb 15;769:145236. doi: 10.1016/j.gene.2020.145236. Epub 2020 Oct 15. Gene. 2021. PMID: 33068674

8

Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease.

Hosseini A, Babaloo Z, Gharibi T, Shomali N, Marofi F, Hashemi V, Ayromlou H, Asadi M, Rahmani S, Noorolyai S, Shanehbandi D, Baradaran B. Hosseini A, et al. Among authors: ayromlou h. BMC Res Notes. 2020 Dec 29;13(1):568. doi: 10.1186/s13104-020-05427-1. BMC Res Notes. 2020. PMID: 33375941 Free PMC article.

9

An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis.

Khademi B, Khorrami M, Ayromlou H, Rikhtegar R, Moghadam EA, Tahmasebivand M, Mousavi SR, Kheirollahi M, Fakhr F, Alizadeh-Ghodsi M, Emamalizadeh B. Khademi B, et al. Among authors: ayromlou h. J Neuroimmunol. 2021 Apr 15;353:577507. doi: 10.1016/j.jneuroim.2021.577507. Epub 2021 Jan 30. J Neuroimmunol. 2021. PMID: 33548618

10

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators.

Dolati S, Ahmadi M, Aghebti-Maleki L, Nikmaram A, Marofi F, Rikhtegar R, Ayromlou H, Yousefi M. Dolati S, et al. Among authors: ayromlou h. Pharmacol Rep. 2018 Dec;70(6):1158-1167. doi: 10.1016/j.pharep.2018.05.008. Epub 2018 May 24. Pharmacol Rep. 2018. PMID: 30340096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page